Acceptable Toxicity After Stereotactic Body Radiation Therapy for Liver Tumors Adjacent to the Central Biliary System

作者：Eriguchi Takahisa; Takeda Atsuya; Sanuki Naoko; Oku Yohei; Aoki Yousuke; Shigematsu Naoyuki; Kunieda Etsuo^*

来源：International Journal of Radiation Oncology, Biology, Physics, 2013, 85(4): 1006-1011.

DOI：10.1016/j.ijrobp.2012.09.012

Purpose: To evaluate biliary toxicity after stereotactic body radiation therapy (SBRT) for liver tumors. %26lt;br%26gt;Methods and Materials: Among 297 consecutive patients with liver tumors treated with SBRT of 35 to 50 Gy in 5 fractions, patients who were irradiated with %26gt;20 Gy to the central biliary system (CBS), including the gallbladder, and had follow-up times %26gt;6 months were retrospectively analyzed. Toxicity profiles, such as clinical symptoms and laboratory and radiologic data especially for obstructive jaundice and biliary infection, were investigated in relation to the dose volume and length relationship for each biliary organ. %26lt;br%26gt;Results: Fifty patients with 55 tumors were irradiated with %26gt;20 Gy to the CBS. The median follow-up period was 18.2 months (range, 6.0-80.5 months). In the dose length analysis, 39, 34, 14, and 2 patients were irradiated with %26gt;20 Gy, %26gt;30 Gy, %26gt;40 Gy, and %26gt;50 Gy, respectively, to %26gt;1 cm of the biliary tract. Seven patients were irradiated with %26gt;20 Gy to %26gt;20% of the gallbladder. Only 2 patients experienced asymptomatic bile duct stenosis. One patient, metachronously treated twice with SBRT for tumors adjacent to each other, had a transient increase in hepatic and biliary enzymes 12 months after the second treatment. The high-dose area %26gt;80 Gy corresponded to the biliary stenosis region. The other patient experienced biliary stenosis 5 months after SBRT and had no laboratory changes. The biliary tract irradiated with %26gt;20 Gy was 7 mm and did not correspond to the bile duct stenosis region. No obstructive jaundice or biliary infection was found in any patient. %26lt;br%26gt;Conclusions: SBRT for liver tumors adjacent to the CBS was feasible with minimal biliary toxicity. Only 1 patient had exceptional radiation-induced bile duct stenosis. For liver tumors adjacent to the CBS without other effective treatment options, SBRT at a dose of 40 Gy in 5 fractions is a safe treatment with regard to biliary toxicity.

• 出版日期2013-3-15